News by BD
Company urges importance of infection prevention and Control, integrated diagnostics, and Lab automation among other key areas
Dubai, United Arab Emirates, June 17, 2021 –
The Dubai Branch of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced that it will bring its latest innovations at this year’s Medlab Middle East, the region’s renowned medical laboratory exhibition taking place from June 21-24, 2021.
“Last year, the world was exposed to undesirable medical extremities,” said Maher Elhassan, Vice President & General Manager, BD Middle East, North Africa & Turkey. “Now is the time when communities in the region and throughout the world need our continued support and expertise to be able to fight all adversaries and recover. As part of our mission to advance the world of health, BD is determined to leave no stone unturned in our quest to impact people’s lives. Our participation at Medlab Middle East reiterates the company’s efforts to support the region’s healthcare sector with our latest innovations that deliver on patient care, safety, diagnostic accuracy, automation and more.”
Through its unprecedented efforts and innovation drive, over the years BD has brought about a significant transformation in the field of medical technology. During Medlab, the company will showcase its latest MedTech innovations such as rapid diagnostic testing solutions to enable caregivers perform high number of tests in a short duration of time; advanced informatics and integrated diagnostics to enhance testing, automate workflows and help expedite decision-making; cutting-edge solutions for microbiology testing to facilitate rapid implementation of infection prevention and control measures; as well as microbiology automation amongst others.
Experts from the BD team will also be present at the company’s booth to host various in-depth sessions, share best practices, and demonstrate an array of innovative solutions to tackle the region’s ongoing healthcare challenges.
“The healthcare sector continues to face challenges ranging from shortage of skilled staff, rising costs, and lack of real time insights that can enable better patient outcomes,” said Shahzad Khan, Regional Business Director EMA, BD Integrated Diagnostic Solutions. “Some of the innovations that we will showcase at this year’s Medlab speak directly to these challenges. Therefore I invite industry professionals to attend the live demonstrations and gain first-hand knowledge on how to overcome such obstacles, and help reshape the future of healthcare.”
BD will exhibit from booth Z4.D10 at Medlab. To attend live sessions, attendees can register here.
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers.
BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians’ care delivery process, enable laboratory scientists to accurately detect disease and advance researchers’ capabilities to develop the next generation of diagnostics and therapeutics.
BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
For more information (Press only):